» Articles » PMID: 23946661

Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease

Overview
Publisher Sage Publications
Specialty Endocrinology
Date 2013 Aug 16
PMID 23946661
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To assess plasma zinc and copper concentration in individuals with autism.

Subjects And Methods: Plasma from 79 autistic individuals, and 18 age and gender similar neurotypical controls, were tested for plasma zinc and copper using inductively-coupled plasma-mass spectrometry.

Results: Autistic individuals had significantly elevated plasma levels of copper and Cu/Zn and lower, but not significantly lower, plasma Zn compared to neurotypical controls. Zn levels increased significantly in autistic individuals with and without GI disease after zinc therapy. Cu decreased significantly after zinc therapy in the GI disease group but not in the autistic group without GI disease. Autistic children significantly improved with respect to hyperactivity and stimming after zinc therapy in autistic children with GI disease. Autistic children without GI disease did not improve in these symptoms after the same therapy.

Discussion: These results suggest an association between zinc and copper plasma levels and autism, and they suggest that zinc therapy may be most effective at lowering copper levels in autistic children with GI disease.

Citing Articles

The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases.

Wan Y, Zhang B Biomolecules. 2022; 12(7).

PMID: 35883455 PMC: 9313088. DOI: 10.3390/biom12070900.


Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey.

Adams J, Bhargava A, Coleman D, Frye R, Rossignol D J Pers Med. 2021; 11(9).

PMID: 34575655 PMC: 8470413. DOI: 10.3390/jpm11090878.


Nutritional status in irritable bowel syndrome: A North American population-based study.

Hujoel I JGH Open. 2020; 4(4):656-662.

PMID: 32782953 PMC: 7411643. DOI: 10.1002/jgh3.12311.


Functional Exploration Of T-Type Calcium Channels (Cav3.2 And Cav3.3) And Their Sensitivity To Zinc.

Hazzaz Abouamal T, Choukairi Z, Taoufiq F Open Microbiol J. 2018; 12:280-287.

PMID: 30197701 PMC: 6110071. DOI: 10.2174/1874285801812010280.


Zinc deficiency and low enterocyte zinc transporter expression in human patients with autism related mutations in SHANK3.

Pfaender S, Sauer A, Hagmeyer S, Mangus K, Linta L, Liebau S Sci Rep. 2017; 7:45190.

PMID: 28345660 PMC: 5366950. DOI: 10.1038/srep45190.


References
1.
Zalewski P, FORBES I, Betts W . Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993; 296 ( Pt 2):403-8. PMC: 1137710. DOI: 10.1042/bj2960403. View

2.
Prasad A . The role of zinc in gastrointestinal and liver disease. Clin Gastroenterol. 1983; 12(3):713-41. View

3.
Rahman M, Rahman F, Rahman T, Kato T . Dopamine-β-Hydroxylase (DBH), Its Cofactors and Other Biochemical Parameters in the Serum of Neurological Patients in Bangladesh. Int J Biomed Sci. 2013; 5(4):395-401. PMC: 3614808. View

4.
Brown R, Sander C, Argos P . The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett. 1985; 186(2):271-4. DOI: 10.1016/0014-5793(85)80723-7. View

5.
Cunnane S . Role of zinc in lipid and fatty acid metabolism and in membranes. Prog Food Nutr Sci. 1988; 12(2):151-88. View